pharmaceuticals-and-healthcare

United States Therapeutic Nuclear Medicines Market Report 2017


Published On : Mar 2017

Category : Pharmaceutical

No. of Pages : 99 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Therapeutic Nuclear Medicines in these regions, from 2012 to 2022 (forecast).

United States Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Nuclear Medicines for each application, including
Hospitals
Ambulatory Surgical Centers
Other

In the recent times, the global market for United states therapeutic nuclear medicines market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states therapeutic nuclear medicines market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states therapeutic nuclear medicines market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states therapeutic nuclear medicines market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states therapeutic nuclear medicines market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states therapeutic nuclear medicines market report 2017, including the definition, classification, and industry chain structure of United states therapeutic nuclear medicines market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states therapeutic nuclear medicines market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states therapeutic nuclear medicines market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states therapeutic nuclear medicines market report 2017, implemented in each of the geographical segments. The predominant applications of the United states therapeutic nuclear medicines market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states therapeutic nuclear medicines market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states therapeutic nuclear medicines market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Therapeutic Nuclear Medicines
Figure United States Therapeutic Nuclear Medicines Market Size (MT) by Type (2012-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture
Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture
Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture
Figure United States Therapeutic Nuclear Medicines Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Other Examples
Figure United States Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2012-2022)
Figure The West Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2022)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure 2017 United States Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure United States Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers
Figure 2017 United States Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers
Table United States Market Therapeutic Nuclear Medicines Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Therapeutic Nuclear Medicines Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Therapeutic Nuclear Medicines Market Share of Top 3 Players/Suppliers
Figure United States Therapeutic Nuclear Medicines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Therapeutic Nuclear Medicines Product Category
Table United States Therapeutic Nuclear Medicines Sales (MT) by Region (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Region in 2016
Table United States Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Revenue Market Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Revenue Market Share by Region in 2016
Table United States Therapeutic Nuclear Medicines Price (USD/MT) by Region (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Type in 2016
Table United States Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2016
Table United States Therapeutic Nuclear Medicines Price (USD/MT) by Types (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Growth Rate by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Application in 2016
Table United States Therapeutic Nuclear Medicines Sales Growth Rate by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Growth Rate by Application (2012-2017)
Table Cardinal Health Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Mallkrodt Plc Basic Information List
Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Lantheus Medical Imaging Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Bracco Imaging SpA Basic Information List
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Nordion Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Advanced Accelerator Applications SA Basic Information List
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table IBA Molecular Imaging Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Players/Suppliers in 2016
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Nuclear Medicines Price (USD/MT) Trend Forecast (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Type in 2022
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Application in 2022
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top